Report overview
Head and neck cancer is a group of cancers that starts in the mouth, nose, throat, larynx, sinuses, or salivary glands.
Current trends indicate that rising geriatric population worldwide, growing cases of target diseases, and availability of improved healthcare services due to government and private organization initiatives will drive the overall market.
This report contains market size and forecasts of Head and Neck Cancer Therapeutics in Global, including the following market information:
Global Head and Neck Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Head and Neck Cancer Therapeutics market was valued at 1064.2 million in 2021 and is projected to reach US$ 1703 million by 2028, at a CAGR of 6.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PD Inhibitors Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Head and Neck Cancer Therapeutics include Sanofi, Eli Lilly, Amgen, Actavis, Dr. Reddy?s Laboratories, Jiangsu Hengrui, Teva Pharmaceutical, DFG and BioXpress. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Head and Neck Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Head and Neck Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Head and Neck Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)
PD Inhibitors
Microtubule Inhibitors
EGFR Inhibitors
Global Head and Neck Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Head and Neck Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)
Surgery
Radiation therapy
Chemotherapy
Immunotherapy
Global Head and Neck Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Head and Neck Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Head and Neck Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Head and Neck Cancer Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Eli Lilly
Amgen
Actavis
Dr. Reddy?s Laboratories
Jiangsu Hengrui
Teva Pharmaceutical
DFG
BioXpress
